摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

O-(3,4,6-tri-O-benzoyl-α-D-mannopyranosyl)-(1->1)-(2S,3R)-2-azido-3-O-benzoyl-1,3-eicosanediol | 1334671-97-4

中文名称
——
中文别名
——
英文名称
O-(3,4,6-tri-O-benzoyl-α-D-mannopyranosyl)-(1->1)-(2S,3R)-2-azido-3-O-benzoyl-1,3-eicosanediol
英文别名
[(2R,3R,4R,5S,6S)-6-[(2S,3R)-2-azido-3-benzoyloxyicosoxy]-3,4-dibenzoyloxy-5-hydroxyoxan-2-yl]methyl benzoate
O-(3,4,6-tri-O-benzoyl-α-D-mannopyranosyl)-(1->1)-(2S,3R)-2-azido-3-O-benzoyl-1,3-eicosanediol化学式
CAS
1334671-97-4
化学式
C54H67N3O11
mdl
——
分子量
934.139
InChiKey
TWKNZTNYAGGGBV-KAGVJCQSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    15.5
  • 重原子数:
    68
  • 可旋转键数:
    34
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    158
  • 氢给体数:
    1
  • 氢受体数:
    13

反应信息

  • 作为反应物:
    描述:
    phenyl 4,6-di-O-benzyl-2-deoxy-3-O-p-methoxybenzyl-1-thio-2-trichloroacetamido-β-D-glucopyranosideO-(3,4,6-tri-O-benzoyl-α-D-mannopyranosyl)-(1->1)-(2S,3R)-2-azido-3-O-benzoyl-1,3-eicosanediolN-碘代丁二酰亚胺三氟甲磺酸 作用下, 以 二氯甲烷 为溶剂, 反应 1.33h, 以87%的产率得到O-(4,6-di-O-benzyl-2-deoxy-3-O-p-methoxybenzyl-2-trichloroacetamido-β-D-glucopyranosyl)-(1->2)-O-(3,4,6-tri-O-benzoyl-α-D-mannopyranosyl)-(1->1)-(2S,3R)-2-azido-3-O-benzoyl-1,3-eicosanediol
    参考文献:
    名称:
    Synthesis of an O-sulfo LewisX analog as glycolipid antigen
    摘要:
    The title compound containing dihydroceramide as a ligand for CD1d was accomplished using the mannosyl, glucosaminyl, and fucosyl donors, and a sphinganine analogue, as suitable building blocks. The 2-O-unprotected mannosyl donor was coupled effectively with the sphinganine analog to afford the mannnosyl sphinganine derivative. The coupling of the glucosaminyl donor with the mannnosyl sphinganine acceptor required triflic acid as a promoter and the promoter change to silver triflate led to the undesired glycal production. The reduction of azide group using Zn powder was the key process, in which the amount of acetic acid was restricted to avoid the benzoyl migration and N-trichloroacetyl deprotection. The trisaccharide glycolipid was sulfonated at the 3-position of fucose moiety. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.carres.2011.06.027
  • 作为产物:
    描述:
    (2S,3R,4E)-2-azido-3-O-benzoyl-4-eicosene-1,3-diol 在 N-碘代丁二酰亚胺 、 palladium on activated charcoal 、 氢气 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 4.33h, 生成 O-(3,4,6-tri-O-benzoyl-α-D-mannopyranosyl)-(1->1)-(2S,3R)-2-azido-3-O-benzoyl-1,3-eicosanediol
    参考文献:
    名称:
    Synthesis of an O-sulfo LewisX analog as glycolipid antigen
    摘要:
    The title compound containing dihydroceramide as a ligand for CD1d was accomplished using the mannosyl, glucosaminyl, and fucosyl donors, and a sphinganine analogue, as suitable building blocks. The 2-O-unprotected mannosyl donor was coupled effectively with the sphinganine analog to afford the mannnosyl sphinganine derivative. The coupling of the glucosaminyl donor with the mannnosyl sphinganine acceptor required triflic acid as a promoter and the promoter change to silver triflate led to the undesired glycal production. The reduction of azide group using Zn powder was the key process, in which the amount of acetic acid was restricted to avoid the benzoyl migration and N-trichloroacetyl deprotection. The trisaccharide glycolipid was sulfonated at the 3-position of fucose moiety. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.carres.2011.06.027
点击查看最新优质反应信息

文献信息

  • Synthesis of an O-sulfo LewisX analog as glycolipid antigen
    作者:Shuhei Ueno、Shigeomi Horito
    DOI:10.1016/j.carres.2011.06.027
    日期:2011.10
    The title compound containing dihydroceramide as a ligand for CD1d was accomplished using the mannosyl, glucosaminyl, and fucosyl donors, and a sphinganine analogue, as suitable building blocks. The 2-O-unprotected mannosyl donor was coupled effectively with the sphinganine analog to afford the mannnosyl sphinganine derivative. The coupling of the glucosaminyl donor with the mannnosyl sphinganine acceptor required triflic acid as a promoter and the promoter change to silver triflate led to the undesired glycal production. The reduction of azide group using Zn powder was the key process, in which the amount of acetic acid was restricted to avoid the benzoyl migration and N-trichloroacetyl deprotection. The trisaccharide glycolipid was sulfonated at the 3-position of fucose moiety. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

鞘磷酯 鞘氨醇半乳糖苷-3'-硫酸酯 西地芬戈 葡糖鞘氨醇半乳糖苷 脑苷脂类 脑苷脂D 脑苷脂 B 神经鞘氨醇半乳糖苷 神经酸酰胺 神经酰胺N-甲基氨基乙基膦酸酯 神经酰胺 神经节苷酯Gm3内酯 神经节苷酯GM1(牛脑) 神经节苷脂GM3 溶血神经酰胺三己糖苷 正二十四烷基二氢-葡糖脑苷脂 己酰神经鞘氨醇 大豆脑苷 I 双唾液酸神经节苷酯GD1A 双唾液酸神经节苷脂GD2 单唾液酸神经节苷酯 十四酰鞘氨醇 人脾脏葡糖苷酰鞘氨醇 二羟基神经酰胺 二十二烷酰胺,N-[1-[(b-D-吡喃葡萄糖氧基)甲基]-2,3-二羟基-5-十七碳烯基]-2-羟基-(9CI) 二十二烷酰胺,N-[(1S,2R,3E,7E,9E)-1-[(b-D-吡喃葡萄糖氧基)甲基]-2-羟基-8-甲基-3,7,9-十七碳三烯-1-基]-2-羟基-,(2R)- 二十二烷酰胺,N-[(1S,2R,3E)-2-羟基-1-(羟甲基)-3-十五碳烯基]- 乳酰基-N-脂酰基鞘氨醇(牛) 乳糖酰基鞘糖脂 乳糖酰基鞘氨醇 β-D-葡萄糖基C4-神经酰胺 alpha-半乳糖基-C16-神经酰胺 [(E,2S,3R)-3-羟基-2-[[(Z)-十八碳-9-烯酰基]氨基]十八碳-4-烯基]2-三甲基铵乙基磷酸酯盐 [(E,2S,3R)-3-羟基-2-[[(Z)-3-芘-1-基丙-2-烯酰基]氨基]十八碳-4-烯基]2-三甲基铵乙基磷酸酯盐 [(E,2S,3R)-3-羟基-2-[11-(芘-1-基磺酰基氨基)十一烷酰基氨基]十八碳-4-烯基]2-三甲基铵乙基磷酸酯盐 [(2R,3S,4S,5R,6R)-3,5-二羟基-2-(羟基甲基)-6-[(E,2S,3R)-3-羟基-2-(二十四烷酰基氨基)十八碳-4-烯氧基]四氢吡喃-4-基]氢硫酸盐 TNPAL-鞘磷脂 O-甘露糖基-(1-3)-O-甘露糖基-(1-4)-O-吡喃葡萄糖基-(1-1)-2-N-二十四烷酰基鞘氨醇 N-(NBD-氨基脲酰)沙丁胺醇 N-辛酰基神经酰胺-1-磷酸酯(铵盐) N-辛酰基4-羟基鞘氨醇(酿酒酵母) N-辛酰基-D-神经鞘氨醇 N-肉豆蔻酰-D-赤型-鞘氨醇 N-神经酰基-D-赤型鞘氨酰基磷酸胆碱 N-硬脂酰神经鞘氨醇 N-硬脂酰植物鞘氨醇 N-硬脂酰基-DL-二氢乳脑苷 N-硬脂酰-dl-二氢-葡糖脑苷脂 N-硬脂酰-D-鞘磷脂 N-癸酰-D-鞘胺醇